
ANTHEM
Anthem Biosciences Limited
- IPO Status
- Closed
- Open Date
- 14 Jul 2025
- Close Date
- 16 Jul 2025
IPO Details
- Min. Investment
- ₹14,820
- Price Band
- ₹540 - ₹570
- Lot Size
- 26 shares
- Issue Size
- ₹3,395 Cr
- Face Value
- 2
- IPO Doc
- —
Schedule
- IPO open14 Jul 2025
- IPO close date16 Jul 2025
- Allotment date17 Jul 2025
- Funds unblock or debit18 Jul 2025
- Listing date21 Jul 2025
Financial Performance
- Revenue
- Profit
Stocks similar to ANTHEM
- Syngene Internatio nal Limited
- Sai Life Sciences Limited
- Cohance Lifescienc es Limited
- Divi's Laboratori es Limited
FAQs
Anthem Biosciences Limited IPO is a Mainboard IPO aggregating up to ₹3,395 Cr, with equity shares of face value ₹2 each. The shares are proposed to be listed on NSE.
The Anthem Biosciences Limited IPO opened on 14 Jul 2025 and closed on 16 Jul 2025. IPO Period: 14 Jul 2025 – 16 Jul 2025.
The price band for the Anthem Biosciences Limited IPO is ₹540 to ₹570 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 26 shares. At the upper price band of ₹570, the minimum investment required is ₹14,820.
Particular Details Lot Size 26 shares Price Band ₹540 – ₹570 Minimum Investment ₹14,820 Maximum Retail Lots 13 Here is the timeline for the Anthem Biosciences Limited IPO:
IPO Event Date IPO Opens 14 Jul 2025 IPO Closes 16 Jul 2025 UPI Mandate Deadline 16 Jul 2025, 5:00 PM Basis of Allotment 17 Jul 2025 Refund Initiation 18 Jul 2025 Shares Credited 18 Jul 2025 Listing Date 21 Jul 2025 The basis of allotment for the Anthem Biosciences Limited IPO is expected to be finalised on 17 Jul 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: KFin Technologies.
The equity shares of Anthem Biosciences Limited are proposed to be listed on NSE. Proposed Listing Date: 21 Jul 2025.
The key financial performance of Anthem Biosciences Limited is:
Financial Year Revenue Profit FY24 ₹1,419.37 Cr ₹367.31 Cr FY25 ₹1,844.55 Cr ₹451.26 Cr FY26 ₹2,124.33 Cr ₹591.79 Cr Revenue CAGR: 22.3% | Profit CAGR: 26.9%. Figures are as disclosed in the company's offer documents.


